Ann: Investor Presentation, page-505

First 505 Last

Share
Profile

Follow
pfeifer1982

1,210 Posts.

3894

17/06/24

20:31

Post #: 74358677
Share

Originally posted by bedger: ↑

There was a comma in there. I was discussing various types of stem cells and you picked out a small ambiquitiy in grammar? Amongst all the ignorant crap that is being incorrectly written about stem cells on here, that I am trying to correct with solid links on research (even FDA research in IPSC's that clearly many ignorant of) and evidence?

No, for clarity Pfeifer, whilst the FDA has approved various autologous stem cells, including chondrocytes, but mainly hematopoietic stem cells and not allogeneic, unless you count Omisirge (omidubicel), and yes, not autlogoous Mesenchymal either. But you might count Chondron, mixing chondrons with allogeneic stem cells in South Korea, or Kaloderm, an allogeneic epidermal cell treatment as 'global approvals'.

And to be a stickler, there has actually been a global approval in an autologous mesenchymal stem cell treatments - unless peopel were to racistly dismiss it - Cupistem, a cultured autologous, adipose-derived mesenchymal stem cell treatment in South Korea.

You may notice above I was citing hematopoietic stem cells above as the exception, for specifically the FDA, until one of our trolls incorrectly dismissed all types of stem cells approvals globally, overlooking that his own invested company was approved in Mesenchymal in three continents.

Fighting the trolls is hard enough (our other one busy disproving his own perverse point that the FDA not courting Cynata or IPSC's some deviation from their normal behaviour as some QED moment for him) without doing battle with you too.

Expand

I wasn't arguing the global approval part, only the US FDA approved part and despite the comma, I still understood it to say autologous MSC treatments were approved by the FDA. I just wanted to clarify
1. the controversy on this in the past and the FDA's action on closing those illegal stem cell clinics that promised miracle cures for all sorts of indications,
2. the fact that no "first-in-class" MSC treatment has been approved in the US because of the FDA's requirements before approving a BLA.

No need to pick a team, no need to start an argument.

CYP Price at posting: 26.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins